ARCHIVES

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

This article is from The Cancer Letter archive.

Vol. 10 No. 07 | February 17, 1984

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Obese Men With Benign Biopsy At High Risk for Prostate Cancer

April 26, 2013

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Russian-American Breast Cancer Meeting Canceled

April 14, 1995